Composition And Formulation Comprising Recombinant Human Iduronate-2-Sulfatase And Preparation Method Thereof

Patent No. EP2723369 (titled "Composition And Formulation Comprising Recombinant Human Iduronate-2-Sulfatase And Preparation Method Thereof") was filed by Green Cross Corporation on Jun 15, 2012. The application was issued on May 10, 2023.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
JAMES POOLEJan 13, 2017CARPMAELS & RANSFORD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2723369

GREEN CROSS CORPORATION
Application Number
EP12803297A
Filing Date
Jun 15, 2012
Status
Patent Maintained As Amended
Apr 7, 2023
Publication Date
May 10, 2023